It promotes collagen production and cartilage regeneration, which are important in bone strength, joint health, and bone repair
Retatrutide does not have an FDA-approved version yet, which means there is currently no legal pathway for a compounding pharmacy to make it. As a result, any vial is unregulated, unsupervised, and off-label, carrying incredible risks regarding purity, dosing, and sterility
Delays Gastric Emptying Slower digestion results in a gradual rise in blood sugar after meals, preventing sharp spikes that can contribute to insulin resistance
Early study results have shown very significant weight loss outcomes, but the medicine must complete further research and pass regulatory assessment before it can be prescribed in the UK